Welcome to our dedicated page for Synaptics SEC filings (Ticker: SYNA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Synaptics Incorporated (Nasdaq: SYNA) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents offer detailed information on Synaptics’ financial performance, governance, compensation programs, and material corporate events related to its Edge AI, semiconductor, and connectivity business.
Investors can review current reports on Form 8-K, where Synaptics reports events such as quarterly and annual financial results, share repurchase authorizations, amendments to its bylaws, and outcomes of its annual meeting of stockholders. For example, recent 8-K filings describe earnings releases for fiscal periods, the launch of a share repurchase program, and changes to the company’s bylaws to address universal proxy rules, remote meetings, and exclusive forum provisions.
The company’s definitive proxy statement on Schedule DEF 14A provides extensive detail on Board composition, director elections, executive compensation, equity and employee stock purchase plans, corporate governance practices, and the agenda for the annual meeting. Voting results on these matters are later summarized in 8-K filings covering the submission of matters to a vote of security holders.
On Stock Titan, these filings are updated as they are made available through EDGAR, and AI-powered summaries help explain the key points in plain language. Users can quickly see what each filing covers, from compensation plan amendments and governance changes to financial condition updates. This page is a resource for anyone analyzing SYNA’s regulatory history, understanding how the company structures its equity programs and governance policies, or tracking material events that Synaptics reports to regulators and investors.
Synaptics Inc officer Vikram Gupta reported an open-market sale of Common Stock. On April 27, 2026, he sold 1,548 shares at an average price of $92.90 per share.
After the transaction, Gupta directly held 87,382 Synaptics shares. The sale was executed under a pre-established Rule 10b5-1 Trading Plan dated March 14, 2024, indicating it was a scheduled, rather than discretionary, trade.
Synaptics Inc director and officer Rahul G. Patel executed an open-market sale of company stock. He sold 2,281 shares of Synaptics common stock at a price of $90.00 per share. After this transaction, he continued to hold 111,320 shares directly. The sale was carried out pursuant to a Rule 10b5-1 trading plan dated September 4, 2025, indicating it was pre-arranged rather than a discretionary trade.
Synaptics Inc. officer Lisa Bodensteiner reported recent stock transactions involving the company’s common shares. On April 20, 2026, she made open-market sales totaling 1,798 shares at weighted-average prices of $81.38 and $82.85 per share, under a Rule 10b5-1 Trading Plan.
On April 17, 2026, 4,210 shares were withheld by Synaptics to cover tax obligations tied to the settlement of restricted stock units, which is not an open-market sale. After these transactions, she directly holds 65,183 shares of Synaptics common stock.
Synaptics Inc. officer Satish Ganesan sold 5,065 shares of common stock at $81.22 per share in an open-market transaction on April 20, 2026, executed under a Rule 10b5-1 trading plan dated September 11, 2025. On April 17, 5,862 shares were disposed of to cover tax withholding tied to the settlement of restricted stock units, which is a non-market event. Following these transactions, Ganesan directly holds 65,750 Synaptics shares, indicating he retains a substantial equity position in the company.
SYNAPTICS Inc executive Vikram Gupta reported an open-market sale of 1,548 shares of Common Stock at $80.95 per share. The sale was made under a Rule 10b5-1 trading plan dated March 14, 2024, indicating it was pre-scheduled rather than opportunistic.
Separately, 5,518 shares were withheld by the company at $80.22 per share to cover tax obligations tied to restricted stock unit settlement, which is a non-market, mechanical disposition. After these transactions, Gupta directly holds 88,930 SYNAPTICS common shares, so the sale represents a small portion of his overall position.
SYNAPTICS Inc officer Ken Rizvi reported a tax-related share disposition. On settlement of restricted stock units, 5,895 shares of common stock were withheld by the company at $80.22 per share to cover tax withholding obligations, rather than sold on the open market.
After this tax-withholding event, Rizvi directly holds 111,984 shares of SYNAPTICS common stock, indicating he retains a substantial equity position following the restricted stock unit settlement.
The filing is a Form 144 notice related to proposed sales of common stock tied to restricted stock units. It lists 3,096 RSUs to be sold by an issuer transaction dated 04/17/2026. The filing also records two prior 10b5-1 sales of 772 shares each on 02/18/2026 and 02/25/2026, with reported proceeds of $65,620.00 and $62,972.04, respectively.
Morgan Stanley Smith Barney LLC submitted a Form 144 reporting proposed and completed dispositions of Common Stock tied to restricted stock units and 10b5-1 plans. The filing lists 1,798 Restricted Stock Units to be sold with an intended sale date of 04/17/2026. It also reports completed 10b5-1 sales of 334 shares on 03/18/2026 (proceeds $24,993.22) and 576 shares on 02/18/2026 (proceeds $48,919.68).